Bioventix PLC
LSE:BVXP
Bioventix PLC
LSE:BVXP
Price:
4 310 GBX
-0.35%
Updated:
May 3, 2024
Bioventix PLC
Revenue
|
Bioventix PLC
Revenue Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bioventix PLC
LSE:BVXP
|
Revenue
£13.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
16%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Revenue
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Revenue
$1.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Revenue
$27m
|
CAGR 3-Years
37%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Revenue
£249.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Revenue
£673.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is Bioventix PLC's Revenue?
Revenue
13.6m
GBP
13.6m
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's Revenue amounts to 13.6m GBP.
What is Bioventix PLC's Revenue growth rate?
Revenue CAGR 10Y
16%
16%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Bioventix PLC have been 10% over the past three years , 9% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
